SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-19-004831
Filing Date
2019-03-26
Accepted
2019-03-26 09:16:15
Documents
4
Period of Report
2019-03-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k032419_adialpharma.htm 8-K 28197
2 CONSULTING AGREEMENT BETWEEN ADIAL PHARMACEUTICALS, INC. AND DR. BANKOLE JOHNSON f8k032419ex10-1_adialpharma.htm EX-10.1 121705
3 PRESS RELEASE, DATED MARCH 26, 2019 f8k032419ex99-1_adialpharma.htm EX-99.1 17414
4 GRAPHIC image_001.jpg GRAPHIC 8241
  Complete submission text file 0001213900-19-004831.txt   180273
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38323 | Film No.: 19704212
SIC: 2834 Pharmaceutical Preparations